Paper36979666
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis.
Picchianti Diamanti A and 21 others. Biomedicines, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis. Papers, record 36979666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979666
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 871029 | Italian Ministry of Health, by the European Union's Horizon 2020 research and innovation pro-gramme under EVA GLOBAL grant | PubMed |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35168944 | Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine. | Ann Rheum Dis | 2022 | https://conductscience.org/library/papers/35168944 | PubMed |
| 2 | 34179831 | Adverse events after first COVID-19 vaccination in patients with autoimmune diseases. | Lancet Rheumatol | 2021 | https://conductscience.org/library/papers/34179831 | PubMed |
| 3 | 34127481 | Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. | Ann Rheum Dis | 2021 | https://conductscience.org/library/papers/34127481 | PubMed |
| 4 | 35746461 | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35746461 | PubMed |
| 5 | 34757289 | A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases. | J Autoimmun | 2021 | https://conductscience.org/library/papers/34757289 | PubMed |
| 6 | 36315075 | COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis. | Rheumatology (Oxford) | 2023 | https://conductscience.org/library/papers/36315075 | PubMed |
| 7 | 34358147 | Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34358147 | PubMed |
| 8 | 20872595 | 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20872595 | PubMed |
| 9 | 34474172 | Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis. | Autoimmun Rev | 2022 | https://conductscience.org/library/papers/34474172 | PubMed |
| 10 | 36473651 | Efficacy and safety of COVID-19 vaccines. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36473651 | PubMed |
| 11 | 31413005 | 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. | Ann Rheum Dis | 2020 | https://conductscience.org/library/papers/31413005 | PubMed |
| 12 | 34476603 | Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis. | Rheumatol Int | 2021 | https://conductscience.org/library/papers/34476603 | PubMed |
| 13 | 36367013 | Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022. | Euro Surveill | 2022 | https://conductscience.org/library/papers/36367013 | PubMed |
| 14 | 34572349 | Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies. | Biomedicines | 2021 | https://conductscience.org/library/papers/34572349 | PubMed |
| 15 | 35309297 | Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35309297 | PubMed |
| 16 | 33494477 | Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33494477 | PubMed |
| 17 | 35471956 | Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases. | JCI Insight | 2022 | https://conductscience.org/library/papers/35471956 | PubMed |
| 18 | 20521925 | Could autoimmunity be induced by vaccination? | Int Rev Immunol | 2010 | https://conductscience.org/library/papers/20521925 | PubMed |
| 19 | 34594343 | ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients. | Front Immunol | 2021 | https://conductscience.org/library/papers/34594343 | PubMed |
| 20 | 34142203 | Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey. | Rheumatol Int | 2021 | https://conductscience.org/library/papers/34142203 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41289027 | Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial. | JCI Insight | 2025 | https://conductscience.org/library/papers/41289027 | PubMed |
| 38932401 | Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38932401 | PubMed |
| 38907947 | What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study. | Drug Saf | 2024 | https://conductscience.org/library/papers/38907947 | PubMed |
| 38137412 | Editorial to the Special Issue "Clinical Immunology in Italy, with Special Emphasis to Primary and Acquired Immunodeficiencies: A Commemorative Issue in Honor of Prof. Fernando Aiuti". | Biomedicines | 2023 | https://conductscience.org/library/papers/38137412 | PubMed |
| 38006015 | Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38006015 | PubMed |
| 37583697 | Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients. | Front Immunol | 2023 | https://conductscience.org/library/papers/37583697 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| NR1I3 | 9970 | PubTator's text mining | https://conductscience.org/library/genes/9970 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979666
GET https://conductscience.org/api/papers/v1/36979666/authors?page=2